Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / GENOMICS IMMUN
-
Total 13F shares
-
1,425,698
-
Share change
-
+319,627
-
Total reported value
-
$65,458,807
-
Price per share
-
$45.94
-
Number of holders
-
62
-
Value change
-
+$14,908,374
-
Number of buys
-
36
-
Number of sells
-
14
Institutional Holders of ISHARES TR - GENOMICS IMMUN (IDNA) as of Q4 2020
As of 31 Dec 2020,
ISHARES TR - GENOMICS IMMUN (IDNA) was held by
62 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,425,698 shares.
The largest 10 holders included
Thrivent Financial for Lutherans, UBS Group AG, RETIREMENT CAPITAL STRATEGIES, LPL Financial LLC, BANK OF AMERICA CORP /DE/, ROYAL BANK OF CANADA, Wealthcare Advisory Partners LLC, FIRST REPUBLIC INVESTMENT MANAGEMENT, INC., STRATEGIC WEALTH MANAGEMENT INC, and STIFEL FINANCIAL CORP.
This page lists
63
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.